Category: Uncategorized
Cresco Labs Announces Opening of 45th Nationwide Dispensary in Sarasota, FL
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the…
TILT’s Commonwealth Alternative Care to Become First Recreational Cannabis Dispensary in Taunton, Massachusetts
TILT Holdings Inc. (“TILT or the “Company”) (NEO: TILT) (OTCQX: TLLTF), a global provider of cannabis business solutions…
AFC Gamma and Viridescent Realty Trust Provide Acreage Holdings with $100 Million Senior Secured Credit Facility
AFC Gamma, Inc. (NASDAQ:AFCG) (“AFC Gamma”) today announced that it has, together with Viridescent Realty…
Curaleaf announces closing of $425 million private placement of 8% senior secured notes due in 2026
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider…
Ascend Wellness Receives New York State Conditional Approval for Investment Agreement with MedMen NY
Ascend Wellness Holdings, Inc. (“AWH” or the “Company”) (CSE: AAWH.U) (OTCQX: AAWH), a multi-state, vertically integrated cannabis…
Captor Retail Group to Open Ninth “One Plant” Retail Dispensary in Palm Springs, California
Captor Capital Corp. (CSE: CPTR; FRANKFURT: NMVA; STUTTGART: NMVA) (“Captor Capital” or the “Company”) is pleased to…
HEXO Reports First Quarter 2022 Results and Launches New Strategic Plan, “The Path Forward”
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus…
MindMed Appoints Robert Barrow as Chief Executive Officer and Director
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the “Company”), a leading biotech company…
Aurora and 22nd Century Group License Foundational Biosynthesis IP to Cronos Group
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) (“Aurora”), the Canadian company defining the future of cannabinoids worldwide,…
Cybin Awarded Notice of Allowance from U.S. Patent and Trademark Office for CYB004 (Deuterated Psychedelic Tryptamine) for the Treatment of Anxiety Disorders
Cybin Inc. ( NEO:CYBN) ( NYSE American:CYBN) (“ Cybin” or the “ Company”), a biopharmaceutical company focused on progressing “Psychedelics…
Recent Comments